期刊文献+

HBV慢性感染与CXC趋化因子表达相关性研究 被引量:6

STUDY ON THE RELATIONSHIP BETWEEN CHRONIC INFECTION OF HBV AND EXPRESSION OF CXC CHEMOKINES
下载PDF
导出
摘要 目的:探讨HBV慢性感染与CXC趋化因子mRNA表达水平的相互关系。方法:以Real-time PCR法动态检测慢性乙肝患者IFN-α联合利巴韦林治疗前、治疗3个月、治疗6个月后IP-10、Mig mRNA的表达水平。以趋化因子与GAPDH比值为其最终含量。结果:慢性乙肝患者HBV-DNA平均水平6.07×10^5 copies/ml,ALT平均水平234.6U/L,IP-10、Mig mRNA表达水平分别为(0.7387±0.0768)、(0.6883±0.0693),与正常对照相比,差异有统计学意义(P〈0.001)。IFN-α治疗3个月后HBV-DNA平均水平1.30×10^4 copies/ml,IP-10、Mig mRNA表达水平分别为(0.5741±0.0912)、(0.5962±0.0987),与治疗前相比,差异有统计学意义(P〈0.001-P〈0.05)。IFN-α治疗6个月后HBV-DNA平均水平3.42×10^3 copies/ml,IP-10、Mig mRNA表达水平分别为(0.4235±0.0924)、(0.4105±0.0898),与治疗前相比,差异有统计学意义(P〈0.001)。IFN-α治疗后,ALT水平正常组IP-10、Mig mRNA也接近正常水平,与同期治疗ALT升高组相比,差异有统计学意义(P〈0.001)。结论:慢性乙肝患者IP-10、Mig mRNA表达升高,与体内HBV-DNA复制水平、血清ALT水平有关。IFN-α能显著抑制HBV复制,间接下调IP-10、Mig mRNA表达水平,IFN这种综合作用效果,对降低患者体内炎性反应、控制病情发展十分有利。 Objective: To study the relationship between chronic infection of HBV and expression of CXC chemokines rnRNA. Methods: The different levels of IP- 10 and Mig mRNA in peripheral blood of chronic hepatitis B were kineticaUy detected by real - time quantitative polymerase chain reaction (Real- time PCR) in different treatment stages of interferon-α (IFN - α). The rate of chemokine/GAPDH was regarded as the extreme level of chemokine. Results: The mean levels of HBV- DNA, alanine aminotransferase (ALT) and expressive levels of IP- 10, Mig mRNA in peripheral blood of patients were 6.07 ×10^5 oopies/ml, 234.6 U/L, (0.7387 ± 0.0768), (0.6883 ±0.0693), respectively. It was significantly different in patients with chronic hepatitis B than that in normal oontrols (P〈0.001). After treatment for three months, the mean level of HBV-DNA and the expressive levlesof IP-10, Mig mRNA were 1.30× 10^4 oopies/ml, (0.4235 ± 0.0924), (0.4105 ± 0.0898), respectively. These were significantly higher than that in normal oontrols (P〈0.001). The expression levels of IP-10 and Mig mRNA in patients with normal ALT were also adjacent to normal level after treatment for six months. There was significant difference in subgroup with high level ALT compared with that in subgroup with mormal level ALT (P〈0.001). Conclusion: This study shows that the expression of IP-10 and Mig mRNA is high in patients with chronic hepatitis B which is associated with the level of replication of HBV and the level of ALT. IFN-α can effectively restrain the replication of HBV and down - regulate the levels of IP- 10 and Mig mRNA to adjacent normal level in patients with chronic hepatitis B. IFN -α plays an important role in down - regulating inflammation response and oontrolling the development of the patients' condition.
出处 《现代预防医学》 CAS 北大核心 2006年第7期1068-1071,共4页 Modern Preventive Medicine
基金 安徽省教育厅自然科学基金重点项目(2003kj027zd)
关键词 乙型肝炎 趋化因子 IFN-Α REAL-TIME PCR Hepatitis B Chemokine interferon-α Real- time quantitative polymerase chain reaction (Real- time PCR)
  • 相关文献

参考文献20

  • 1Fjuiie S.Hieshima K.lzawa D.et al.Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB[J].Int Immunol,2001,13(10):1255-1263.
  • 2Trebst C.Staugaitis SM.Tucky B.et al.Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS)[J].Neuropathol Appl Neurobiol,2003,29 (6):584-595.
  • 3Guidotti LG,Morris A,Mendez H,et al.Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice[J].J Virol,2002,76 (6):2617-2621.
  • 4Schalm SW,Heathcote J,Ganciara J,et al.Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection:a randomised trial[J].Gut,2000,46 (4):562-568.
  • 5中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 6Shields PL,Morland CM,Salmon M,et al.Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver[J].J Immunol,1999,163 (11):6236-6243.
  • 7Apolinario A.Majano PL.Lorente R.et al.Gene expression protile of T-cell-specific chemokines in human hepatocyte-derived cells:evidence for a synergistic iducer effect of cytokines and hepatitis C virus proteins[J].J Viral Hepatol,2005,12 (1):27-37.
  • 8Sypsa VA.Mimidis K.Tassopoulos NC,et al.A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative[J].Hepatdogy,2005,42 (1):77-85.
  • 9combination treatment of patients with chronic hepatitis B infection:a randomised trial[J].Gut,2000,46 (4):562-568.
  • 10尚慧,金颖,石桂华.干扰素联合拉米夫定治疗慢性乙型肝炎的临床用药研究[J].药物生物技术,2004,11(4):264-266. 被引量:1

二级参考文献35

  • 1Krogsgaard K,Bindslev N,Christensen E,et al.The treatment effect of alpha-interferon in chronic hepatitis B is independent of pre-treatment variables [J].J Hepatol,1994,21:645.
  • 2Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med, 1992, 327: 1899-1905.
  • 3Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med, 2002, 347: 975-982.
  • 4Fanning LJ, Kenny-Walsh E, Shanahan F. Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1. Hum Immunol, 2004, 659: 745-751.
  • 5McKiernan SM, Hagan R, Curry M, et al. Distinct MHC class Ⅰ and Ⅱ alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology, 2004, 40: 108-114.
  • 6Barrett S, Collins M, Kenny C, et al. Polymorphisms in tumour necrosis actor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol, 2003, 71: 212-218.
  • 7Konishi I, Horiike N, Hiasa Y, et al. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan. Intervirology, 2004, 47: 114-120.
  • 8Hellier S, Frodsham AJ, Hennig BJ, et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology, 2003, 38: 1468-1476.
  • 9Khabar KS, Polyak SJ. Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems. J Interferon Cytokine Res, 2002, 22: 1005-1012.
  • 10Soo HM, Garzino-Demo A, Hong W, et al. Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology, 2002, 303: 253-277.

共引文献14014

同被引文献54

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部